Safe Muscle Relaxants for Elderly Patients with Impaired Renal Function and Orthostatic Hypotension

General Considerations for Muscle Relaxants in the Elderly

• Muscle relaxants as a class are listed in the American Geriatrics Society Beers Criteria as potentially inappropriate medications for older adults due to anticholinergic effects, sedation, and increased risk of falls 1
• Most muscle relaxants do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain, making their use questionable in elderly patients 2
• Given the potential for adverse effects in older adults, these drugs are generally not favored for chronic pain management 2

Specific Muscle Relaxant Options

• The American Geriatrics Society recommends avoiding cyclobenzaprine in elderly patients as it is structurally similar to tricyclic antidepressants with comparable adverse effect profiles 1
• Cyclobenzaprine is listed in the polypharmacy management guidelines as a medication with risks in older adults due to CNS impairment, delirium, slowed comprehension, and falling 3
• Methocarbamol elimination is significantly impaired in patients with liver and kidney disease 4
• Methocarbamol can cause drowsiness, dizziness, and cardiovascular effects including bradycardia and hypotension 4
• Metaxalone is contraindicated in patients with significant hepatic or renal dysfunction 4
• Metaxalone has multiple central nervous system adverse effects, including drowsiness, dizziness, and irritability 4
• Orphenadrine has anticholinergic properties that can cause confusion, anxiety, tremors, urinary retention, and cardiovascular instability 4
• Orphenadrine should be used with caution in patients with cardiac issues and in the elderly 4

Monitoring and Management Recommendations

• The American College of Physicians recommends considering non-pharmacological approaches for muscle spasm management first 1
• For patients with musculoskeletal pain, the American Geriatrics Society suggests considering topical analgesics which may provide relief with fewer systemic side effects 1
• Scheduled acetaminophen may be effective for mild to moderate musculoskeletal pain in elderly patients, according to the Mayo Clinic Proceedings 3

Muscle Relaxant Recommendations for Elderly Patients

General Considerations

• The American Geriatrics Society recommends that muscle relaxants be used with caution in elderly patients due to their potential for anticholinergic effects, sedation, and increased risk of falls 5
• Most muscle relaxants have limited evidence of efficacy for chronic pain management in elderly patients, and their use should be carefully considered 6

Recommended Options

• The American Geriatrics Society suggests that baclofen is a preferred muscle relaxant for elderly patients, with a recommended starting dose of 5 mg up to three times daily, and a maximum tolerated dose of 30-40 mg per day 7
• Tizanidine is also a recommended option, with a starting dose of 2 mg up to three times daily, and should be used with caution in renally impaired patients, with monitoring for orthostatic hypotension, sedation, and potential drug-drug interactions 7

Muscle Relaxants to Avoid in Elderly

• Carisoprodol should be avoided in elderly patients due to its high risk of sedation and falls, and has been removed from the European market due to concerns about drug abuse 6
• Orphenadrine is listed in the Beers Criteria as potentially inappropriate for older adults due to its strong anticholinergic properties 5

Dosing Considerations

• The American Geriatrics Society recommends starting with the lowest possible effective dose and using muscle relaxants for the shortest duration necessary 5, 7
• For baclofen, older persons rarely tolerate doses greater than 30-40 mg per day 7
• For tizanidine, the dose should be started at 2 mg and titrated slowly while monitoring for side effects 7

Key Pitfalls to Avoid

• The American Geriatrics Society advises avoiding the prescription of muscle relaxants with other medications that have anticholinergic properties 5
• Abrupt discontinuation of baclofen should be avoided due to the risk of withdrawal symptoms, including CNS irritability 7

Muscle Relaxant Therapy in Elderly Patients

Introduction to Muscle Relaxants

• Baclofen is a gamma amino butyric acid type B agonist with documented efficacy for muscle spasm and spasticity, particularly in patients with CNS injury and neuromuscular disorders, and is recommended by the American Geriatrics Society as the preferred agent for elderly patients requiring muscle relaxant therapy 8
• Starting with low doses (5 mg three times daily) and gradual titration minimizes common side effects of dizziness, somnolence, and gastrointestinal symptoms, and the American Geriatrics Society recommends this approach 8

Safety Considerations

• All muscle relaxants are associated with a greater risk for falls in older persons, and should be used with caution 8
• Abrupt discontinuation of baclofen must be avoided due to the risk of withdrawal symptoms including CNS irritability, and discontinuation after prolonged use requires slow tapering 8

Alternative Therapies

• Benzodiazepines may be justified for a trial of muscle spasm relief, especially when anxiety, muscle spasm, and pain coexist, but the high-risk profile in older adults usually obviates any potential benefit 8
• Current evidence does not support a direct analgesic effect of benzodiazepines, and non-pharmacological approaches should be considered first before initiating any muscle relaxant therapy 8

Safer Alternatives to Methocarbamol for Elderly Patients

Introduction to Baclofen

• The American Geriatrics Society recommends baclofen as a preferred muscle relaxant for elderly patients, with a dosing strategy that starts at 5 mg three times daily and titrates gradually, increasing weekly by small increments, to minimize dizziness, somnolence, and gastrointestinal symptoms, with a maximum tolerated dose of 30-40 mg per day 9
• Baclofen has documented efficacy as a GABA-B agonist for muscle spasm and spasticity, particularly in CNS injury and neuromuscular disorders, with fair evidence for effectiveness in spasticity conditions 9

Critical Safety Warnings for Baclofen

• Baclofen should never be discontinued abruptly, requiring slow tapering to avoid withdrawal symptoms including delirium, seizures, and CNS irritability, according to the American Geriatrics Society 9

Key Clinical Considerations

• Most muscle relaxants do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain, with nonspecific effects, and should not be prescribed believing they relieve muscle spasm, unless true spasm is suspected, in which case baclofen or benzodiazepines are more appropriate, as noted by the American Geriatrics Society 9
• Benzodiazepines have no direct analgesic effect and their high-risk profile in older adults usually obviates any benefit, though may be justified when anxiety, muscle spasm, and pain coexist, according to the American Geriatrics Society 9

Muscle Relaxant Use in Elderly Patients

Agents to Avoid

• Cyclobenzaprine should be held on the day of surgery due to potential interactions with anesthetics and sedatives, as recommended by the Mayo Clinic Proceedings 10
• Carisoprodol is classified as a controlled substance with substantial abuse and addiction potential, and should be avoided in elderly patients, according to the Mayo Clinic Proceedings 10
• Carisoprodol should be tapered off or switched to an alternative agent before surgical procedures, if time permits, as suggested by the Mayo Clinic Proceedings 10
• Metaxalone is contraindicated in patients with significant hepatic or renal dysfunction and has multiple CNS adverse effects, as noted by the Mayo Clinic Proceedings 10
• Tizanidine should be avoided in older adults due to significant sedation and hypotension, and is contraindicated in elderly patients per SPAQI guidelines, as recommended by the Mayo Clinic Proceedings 10

Patient Populations to Avoid

• Muscle relaxants should be avoided in frail patients with mobility deficits, weight loss, weakness, or cognitive deficits, as recommended by The Journal of Urology 11

Muscle Relaxant Therapy in Elderly Patients

Introduction to Muscle Relaxant Options

• Most muscle relaxants do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain, they should only be used when true muscle spasm or spasticity is suspected, according to the American Geriatrics Society 12

Alternative Treatment Options

• If the patient's condition is primarily neuropathic pain rather than true spasticity, consider gabapentinoids (pregabalin, gabapentin) or duloxetine instead, which have stronger evidence for neuropathic pain in elderly patients, as recommended by the American Geriatrics Society 12

Tizanidine for Acute Muscle Spasm in Older Adults

Efficacy Evidence

• In eight randomized clinical trials involving adults with acute low‑back pain, tizanidine provided moderate short‑term pain relief (2–4 days) that was statistically superior to placebo. The American Geriatrics Society cites this evidence as moderate quality. 13

Recommended Duration of Therapy

• Guidelines advise using tizanidine for the briefest period necessary, typically ≤ 2 weeks, when treating acute muscle spasm in elderly patients, to minimize cumulative adverse effects. This recommendation is based on the same 2007 evidence base. 13

Alternative Topical Analgesics

• A 2020 systematic review in the Journal of the American Geriatrics Society found that topical analgesic preparations (e.g., lidocaine or diclofenac gels) can relieve focal musculoskeletal pain in older adults with fewer systemic side effects compared with oral agents. Evidence level was classified as moderate. 14